CTNM
Contineum Therapeutics Inc.
$11.63
-$1.44(-11.02%)
54
Overall
60
Value
63
Tech
39
Quality
Market Cap
$340.56M
Volume
1.50M
52W Range
$3.35 - $15.25
Target Price
$22.00
Key Metrics Overview
| Market Cap | $340.56M | P/E Ratio | N/A |
| 52W High | $15.25 | 52W Low | $3.35 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 69.6% |
| Overall Score | 54 | Value Score | 60 |
| Quality Score | 39 | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-2.21 | EPS Next Est | $-2.25 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $11.63 | -11.0% | 1.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW